TARBENT Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

tarbent

zentiva italia s.r.l. - tapentadol - tapentadol

EMPRESSIN Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

empressin

orpha-devel handels und vertriebs gmbh - vasopressina - vasopressina

PARACETAMOLO PHARMA BAVARIA INTERNACIONAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

paracetamolo pharma bavaria internacional

pharma bavaria internacional (pbi) portugal, unipessoal lda - paracetamolo - paracetamolo

TRESUVI Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

tresuvi

orpha-devel handels und vertriebs gmbh - treprostinil - treprostinil

ESMOCARD Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

esmocard

orpha-devel handels und vertriebs gmbh - esmololo - esmololo

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Unione Europea - italiano - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - ormoni ipofisari e ipotalamici e analoghi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Lutetium (177Lu) chloride Billev (previously Illuzyce) Unione Europea - italiano - EMA (European Medicines Agency)

lutetium (177lu) chloride billev (previously illuzyce)

billev pharma aps - lutetium (177lu) chloride - imaging dei radionuclidi - radiofarmaci terapeutici - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Increxxa Unione Europea - italiano - EMA (European Medicines Agency)

increxxa

elanco gmbh - tulatromicina - antibatterici per uso sistemico - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. la presenza della malattia nella mandria deve essere stabilita prima del trattamento metafilattico. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. la presenza della malattia nella mandria deve essere stabilita prima del trattamento metafilattico. the product should only be used if pigs are expected to develop the disease within 2–3 days. pecora: trattamento delle prime fasi di pododermatite infettiva (marciume del piede) associata a dichelobacter nodosus virulento che richiede un trattamento sistemico.